Emerald Mutual Fund Advisers Trust increased its stake in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Free Report) by 20.5% in the first quarter, HoldingsChannel.com reports. The firm owned 789,591 shares of the company’s stock after buying an additional 134,576 shares during the period. Amylyx Pharmaceuticals accounts for approximately 1.4% of Emerald Mutual Fund Advisers […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) has been given a consensus rating of “Moderate Buy” by the six brokerages that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating and five have issued a buy rating on the company. The average 1-year price objective […]
Tang Capital Management LLC bought a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 100,000 shares of the company’s stock, valued at approximately $3,695,000. Tang Capital Management LLC owned approximately […]
Oversea Chinese Banking CORP Ltd bought a new position in shares of Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 16,785 shares of the company’s stock, valued at approximately $620,000. Several other hedge funds and […]
Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX – Get Rating) – Stock analysts at SVB Leerink reduced their FY2025 EPS estimates for shares of Amylyx Pharmaceuticals in a research note issued to investors on Tuesday, May 30th. SVB Leerink analyst M. Goodman now forecasts that the company will post earnings of $6.35 per share for the year, down […]